Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Hill and Dr Stuart were concerned about the risks of hepatitis and were of the view that it would have been advantageous to reserve NHS Factor 8 for children.

  • Read more about Dr Hill and Dr Stuart were concerned about the risks of hepatitis and were of the view that it would have been advantageous to reserve NHS Factor 8 for children.

Professor Frank Hill at the time believed hepatitis was a minor self limiting condition with no serious long-term consequences

  • Read more about Professor Frank Hill at the time believed hepatitis was a minor self limiting condition with no serious long-term consequences

In 1979 almost no cryoprecipitate was used and the amount of commercial concentrate was well over double the amount of NHS concentrate at the Birmingham Haemophlia Centre

  • Read more about In 1979 almost no cryoprecipitate was used and the amount of commercial concentrate was well over double the amount of NHS concentrate at the Birmingham Haemophlia Centre

During 1978 little cryoprecipitate was used and the NHS and commercial factor VIII levels broadly remained similar to the year before at the Birmingham Haemophilia Centre

  • Read more about During 1978 little cryoprecipitate was used and the NHS and commercial factor VIII levels broadly remained similar to the year before at the Birmingham Haemophilia Centre

Dr Stuart of Queen Elizabeth Hospital stated that only a third of Queen Elizabeth Hospital's Factor 8 product was received from the Lister, meaning the two-thirds shortfall had to be made up with commercial concentrates.

  • Read more about Dr Stuart of Queen Elizabeth Hospital stated that only a third of Queen Elizabeth Hospital's Factor 8 product was received from the Lister, meaning the two-thirds shortfall had to be made up with commercial concentrates.

During 1977 Queen Elizabeth Hospital used significant amounts of commercial Factor 8 as well as NHS Factor 8

  • Read more about During 1977 Queen Elizabeth Hospital used significant amounts of commercial Factor 8 as well as NHS Factor 8

At a Working Party meeting Dr Stuart stated that during 1976 Queen Elizabeth Hospital had used 500,000 units of commercial Factor 8 for home treatment, with all the NHS product having been used for treatment in hospital and for dental cases. He stated that his preference was to have all his Factor 8 from the same source, and that he was minded to discontinue cryoprecipitate as a home treatment and use NHS product instead.

  • Read more about At a Working Party meeting Dr Stuart stated that during 1976 Queen Elizabeth Hospital had used 500,000 units of commercial Factor 8 for home treatment, with all the NHS product having been used for treatment in hospital and for dental cases. He stated that his preference was to have all his Factor 8 from the same source, and that he was minded to discontinue cryoprecipitate as a home treatment and use NHS product instead.

During 1977 the Queen Elizabeth Hospital used significant amounts of commercial Factor 8 (almost double the amount from the previous year) as well as NHS Factor 8 (at a similar level to the previous year)

  • Read more about During 1977 the Queen Elizabeth Hospital used significant amounts of commercial Factor 8 (almost double the amount from the previous year) as well as NHS Factor 8 (at a similar level to the previous year)

In 1976 the Queen Elizabeth Hospital had used 500,000 units of commercial Factor 8 for home treatment, because all the NHS product having been used for treatment in hospital and for dental cases.

  • Read more about In 1976 the Queen Elizabeth Hospital had used 500,000 units of commercial Factor 8 for home treatment, because all the NHS product having been used for treatment in hospital and for dental cases.

Demand for cryoprecipitate was going down and NHS concentrates were not being used at the rate that had been predicted

  • Read more about Demand for cryoprecipitate was going down and NHS concentrates were not being used at the rate that had been predicted

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 61
  • Page 62
  • Page 63
  • Page 64
  • Current page 65
  • Page 66
  • Page 67
  • Page 68
  • Page 69
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.